Parallax Volatility Advisers’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,400
| Closed | -$1.37M | – | 1735 |
|
|
2024
Q4 | $1.37M | Buy |
+24,400
| New | +$1.52M | ﹤0.01% | 1243 |
|
|
2024
Q3 | – | Sell |
-22,600
| Closed | -$955K | – | 2099 |
|
|
2024
Q2 | $955K | Sell |
22,600
-63,400
| -74% | -$3.49M | ﹤0.01% | 1275 |
|
|
2024
Q1 | $5.94M | Sell |
86,000
-229,000
| -73% | -$14.5M | 0.01% | 671 |
|
|
2023
Q4 | $23.3M | Buy |
315,000
+25,300
| +9% | +$1.66M | 0.05% | 350 |
|
|
2023
Q3 | $19.8M | Buy |
289,700
+112,300
| +63% | +$9.53M | 0.04% | 343 |
|
|
2023
Q2 | $16.7M | Buy |
177,400
+155,700
| +718% | +$12.1M | 0.04% | 395 |
|
|
2023
Q1 | $1.47M | Sell |
21,700
-13,800
| -39% | -$887K | ﹤0.01% | 1344 |
|
|
2022
Q4 | $1.76M | Sell |
35,500
-47,700
| -57% | -$1.95M | ﹤0.01% | 1447 |
|
|
2022
Q3 | $2.7M | Buy |
83,200
+72,200
| +656% | +$2.98M | ﹤0.01% | 1277 |
|
|
2022
Q2 | $433K | Buy |
11,000
+10,900
| +10,900% | +$583K | ﹤0.01% | 1969 |
|
|
2022
Q1 | $7K | Sell |
100
-1,400
| -93% | -$102K | ﹤0.01% | 2696 |
|
|
2021
Q4 | $117K | Buy |
1,500
+200
| +15% | +$17.7K | ﹤0.01% | 1725 |
|
|
2021
Q3 | $124K | Buy |
+1,300
| New | +$137K | ﹤0.01% | 1755 |
|
|
2020
Q4 | – | Sell |
-3,000
| Closed | -$303K | – | 2927 |
|
|
2020
Q3 | $303K | Sell |
3,000
-41,000
| -93% | -$3.54M | ﹤0.01% | 2398 |
|
|
2020
Q2 | $3.83M | Buy |
44,000
+42,500
| +2,833% | +$3.4M | ﹤0.01% | 1191 |
|
|
2020
Q1 | $87K | Sell |
1,500
-122,500
| -99% | -$9.95M | ﹤0.01% | 2171 |
|
|
2019
Q4 | $11.5M | Sell |
124,000
-19,300
| -13% | -$1.7M | 0.01% | 605 |
|
|
2019
Q3 | $12.9M | Buy |
143,300
+73,300
| +105% | +$8.35M | 0.01% | 521 |
|
|
2019
Q2 | $8.26M | Buy |
+70,000
| New | +$7.05M | 0.01% | 573 |
|
|
2019
Q1 | – | Sell |
-33,700
| Closed | -$2.13M | – | 3081 |
|
|
2018
Q4 | $2.13M | Sell |
33,700
-41,000
| -55% | -$2.81M | ﹤0.01% | 1040 |
|
|
2018
Q3 | $5.9M | Sell |
74,700
-37,000
| -33% | -$2.41M | 0.01% | 651 |
|
|
2018
Q2 | $6.68M | Buy |
111,700
+86,100
| +336% | +$4.63M | 0.01% | 536 |
|
|
2018
Q1 | $1.03M | Sell |
25,600
-55,100
| -68% | -$2.69M | ﹤0.01% | 955 |
|
|
2017
Q4 | $4.24M | Buy |
+80,700
| New | +$4.31M | 0.01% | 661 |
|
|
2017
Q3 | – | Sell |
-45,000
| Closed | -$1.59M | – | 2391 |
|
|
2017
Q2 | $1.59M | Buy |
45,000
+9,000
| +25% | +$278K | ﹤0.01% | 913 |
|
|
2017
Q1 | $850K | Buy |
+36,000
| New | +$713K | ﹤0.01% | 1231 |
|
|
2016
Q3 | – | Sell |
-11,700
| Closed | -$143K | – | 3129 |
|
|
2016
Q2 | $143K | Buy |
+11,700
| New | +$88.1K | ﹤0.01% | 1916 |
|
Other funds holding EXAS
Parallax Volatility Advisers's EXAS Position: Q3 2024 in Review
Parallax Volatility Advisers sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 686 shares — an estimated $29K sold.
Parallax Volatility Advisers first reported a position in EXAS in Q3 2017 and held it in 20 quarters. The position peaked at $3.19M in Q3 2021. 599 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.
- Parallax Volatility Advisers reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
- Parallax Volatility Advisers sold 686 Exact Sciences shares in Q3 2024, an estimated $29K.
- Parallax Volatility Advisers first reported a position in Exact Sciences in Q3 2017 and held it in 20 quarters.
- Parallax Volatility Advisers's Exact Sciences position peaked at $3.19M in Q3 2021.
- 599 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.
Based on Parallax Volatility Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.